Rote Liste in Transition: From Print Edition to Digital Platform for Medicines Information

For over 90 years, Rote Liste has been synonymous with reliable, unbiased information on medications. What began as a printed price list has evolved into a modern digital information platform. One thing has remained constant throughout: the commitment to providing well-researched, ad-free information.

A look at its evolution shows how Rote Liste has adapted to new demands and actively helped shape the transformation of medicines information.

The indispensable standard reference work for pharmacists and doctors - the beginnings

The first edition of Rote Liste was published under the title “Price List of German Pharmaceutical Specialty Preparations.” Even back then, there was a clear need for well-researched, structured medicines information. With the ROTE LISTE® entries offered by Rote Liste Service GmbH, physicians and pharmacists gained, for the first time, a central, reliable source of unbiased medicines information in Germany.

Over the decades, the publication evolved into an indispensable standard for doctors and pharmacists - initially available exclusively in print. From the very beginning, reliability and the absence of advertising shaped its content, and these remain key quality characteristics of Rote Liste solutions to this day.

The Publication of Digital ROTE LISTE® Entries

In 1990, an important step followed with the introduction of electronic data carriers for ROTE LISTE® entries. Eight years later, the platform finally went online, heralding a new era: in addition to the traditional book, the content was now also available digitally. Step by step, ROTE LISTE® thus evolved from a static reference work into a dynamic source of information.

ROTE LISTE® Today: Digital Solutions for Reliable and User-Friendly medicines Information

Today, Rote Liste offers far more than a traditional reference work. Users can choose from a broad portfolio of solutions that make medicines information accessible through various channels - both digital and offline. The content is accessible at any time and in a user-friendly manner.

In addition to the ROTE LISTE® entries, the portfolio includes, among other things, the Therapeutics Database, which provides structured and centrally available information on medications at the therapeutic level. Patients also benefit from innovative offerings: With GI 4.0® (Electronic Package Leaflet), Rote Liste enables mobile and user-friendly access to medicines information.

Rote Liste thus combines in-depth expertise with innovative technologies to reliably provide pharmaceutical information. Since 2025, Rote Liste has been part of the cormeo group as a subsidiary of Bertelsmann Investments, integrating it into a strong network that actively shapes the digital transformation in healthcare and provides key impetus for the further development of medicines information.

Blog Post Visual_RL Damals und heute

The Future of Medicines Information - Driven by Rote Liste

Current developments make it clear: The future of medicines information is digital and is evolving dynamically, for example through electronic Product Information (ePI).

Rote Liste is also actively driving these developments at the European level. As one of the founding members of the Alliance for Medicines Information (AMI), Rote Liste supports an initiative dedicated to the harmonized and interconnected provision of information about medicines across Europe.

In doing so, Rote Liste continues to pursue the goal it has held since its founding: to make high-quality, comprehensive medicines information easily accessible so that it supports informed decision-making in healthcare - always in line with modern developments.